Pay in 4 interest-free payments of $6.95 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Through activating canonical or non-canonical signaling pathways, the HGF/c-Met axis mediates a range of oncogenic processes such as cell proliferation, invasion, apoptosis, and angiogenesis and is increasingly becoming a promising target for cancer therapy
A Long-Acting Selective Neuropeptide Y2 Receptor PEGylated Peptide Agonist Reduces Food Intake in Mice
Semaglutide-Induced Ischemic Colitis in A Middle-Aged Female Without Vascular Risk Factors
Quality assessment The quality of the included studies was assessed using RoB2 for RCTs and ROBINS-I for observational studies
Novo says it delivered 15% weight loss in a late-stage trial
Published pharmacokinetic data for both peptides remain limited
